Fidelity Advisor Health Care Fund Class M (FACTX) Fund Overview
Educational signal · not a buy or sell recommendation · How to read this
Beta 0.85: the stock has moved about 15% less than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerFidelity Advisor Health Care Fund Class M (FACTX) trades at $57.59. Fidelity Advisor Health Care Fund Class M (FACTX) is a mutual fund focused on investing in the healthcare sector. Sector: Financials.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for FACTX: FACTX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
Fidelity Advisor Health Care Fund Class M (FACTX) Financial Services Profile
Fidelity Advisor Health Care Fund Class M (FACTX) is a financial services fund specializing in healthcare investments, leveraging fundamental analysis to select domestic and foreign issuers within the health care and medicine sectors, offering investors exposure to this specific market segment with a beta of 0.85.
What Is the Investment Thesis for FACTX?
Fidelity Advisor Health Care Fund Class M (FACTX) presents an investment opportunity for those seeking targeted exposure to the healthcare sector. With a market cap of $3.15 billion and a beta of 0.85, the fund offers a focused approach to investing in companies involved in healthcare and medicine. The fund's strategy of investing at least 80% of its assets in healthcare-related securities aligns it directly with the growth trends in the industry. Catalysts include ongoing advancements in medical technology and increasing global healthcare spending. However, potential risks include regulatory changes and competitive pressures within the healthcare industry. The fund's fundamental analysis approach aims to mitigate these risks by identifying companies with strong financials and industry positioning. The absence of a dividend yield suggests a focus on capital appreciation rather than income generation.
Based on FMP financials and quantitative analysis
FACTX Key Highlights
Market Cap: $3.15B indicating substantial assets under management.
- Beta: 0.85 suggests lower volatility compared to the overall market.
- Focus on Healthcare Sector: At least 80% of assets invested in healthcare-related companies.
- Global Exposure: Investments in both domestic and foreign issuers.
- Fundamental Analysis: Investment decisions based on company financials and industry position.
Who Are FACTX's Competitors?
FACTX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| EAGL Eagle Capital Select Equity ETF | $34.68 | +1.85% | $4.41B | — |
| FACDX Fidelity Advisor Health Care Fund Class A | $66.43 | +1.79% | $3.46B | — |
| FBMPX Fidelity Select Multimedia Portfolio | $145.05 | +1.21% | $2.82B | — |
| FELIX Fidelity Advisor Semiconductors Fund | $207.10 | +0.89% | $6.29B | — |
| FHCCX Fidelity Advisor Health Care Fund Class C | $43.32 | +1.76% | $3.45B | — |
| BLK BlackRock, Inc. | $1066.45 | +0.64% | $165B | 51 5-pillar |
| BX Blackstone Inc. | $111.64 | -0.09% | $136B | 68 5-pillar |
| APOS Apollo Global Management, Inc. | $25.59 | 0.00% | $74.8B | 56 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are FACTX's Key Strengths?
Specialized focus on the healthcare sector.
- Experienced management team at Fidelity Investments.
- Diversified portfolio of healthcare stocks.
- Access to Fidelity's research and resources.
What Are FACTX's Weaknesses?
Concentrated sector exposure increases risk.
- Performance is highly dependent on the healthcare industry's performance.
- Subject to regulatory and political risks in the healthcare sector.
- No dividend yield may deter some investors.
What Are the Key Risks for FACTX?
Regulatory changes and healthcare reforms impacting profitability.
- Increased competition among healthcare companies.
- Economic downturns reducing healthcare spending.
- Patent expirations and generic drug competition affecting pharmaceutical companies.
- Geopolitical risks impacting global healthcare supply chains.
What Are FACTX's Competitive Advantages?
- Established Brand: Fidelity Investments has a strong reputation and brand recognition in the asset management industry.
- Experienced Management Team: The fund is managed by experienced professionals with expertise in healthcare investing.
- Diversified Portfolio: The fund's investments are diversified across various healthcare sub-sectors and geographies.
What Does FACTX Do?
Fidelity Advisor Health Care Fund Class M (FACTX) is a mutual fund managed by Fidelity Investments, one of the world's largest asset managers. The fund is designed to provide investors with exposure to the healthcare sector, investing primarily in the common stocks of companies that are principally engaged in the design, manufacture, or sale of products or services used for or in connection with health care or medicine. This includes a broad range of companies, from pharmaceutical and biotechnology firms to medical device manufacturers and healthcare service providers. The fund invests in both domestic and foreign issuers, allowing it to capture opportunities in the global healthcare market. Fidelity employs a fundamental analysis approach to select investments, evaluating factors such as each issuer's financial condition, industry position, and overall market and economic conditions. This bottom-up approach aims to identify companies with strong growth potential and sustainable competitive advantages within the healthcare sector. FACTX offers a specific focus within the broader market, targeting companies directly involved in advancing healthcare technologies and services. The fund's investment strategy seeks to deliver long-term capital appreciation by capitalizing on the growth trends and innovation within the healthcare industry.
What Products and Services Does FACTX Offer?
- Invests primarily in common stocks of healthcare companies.
- Targets companies involved in the design, manufacture, or sale of healthcare products and services.
- Invests at least 80% of its assets in healthcare-related securities.
- Invests in both domestic and foreign issuers.
- Uses fundamental analysis to select investments.
- Aims to provide long-term capital appreciation.
How Does FACTX Make Money?
- Generates revenue through capital appreciation of its investments.
- Charges management fees to investors based on assets under management.
- Reinvests dividends and capital gains to enhance portfolio value.
What Industry Does FACTX Operate In?
Fidelity Advisor Health Care Fund Class M (FACTX) operates within the asset management industry, focusing specifically on the healthcare sector. The healthcare industry is characterized by continuous innovation, increasing demand due to aging populations, and evolving regulatory landscapes. The fund competes with other healthcare-focused funds and broader market index funds. The asset management industry is experiencing growth driven by increasing investor interest in specialized investment strategies. Competitors include funds like EAGL, FACDX, FBMPX, FELIX, and FHCCX, each with varying investment strategies and risk profiles within the healthcare sector.
Who Are FACTX's Key Customers?
- Individual investors seeking exposure to the healthcare sector.
- Institutional investors looking for specialized healthcare investments.
- Financial advisors recommending healthcare-focused funds to their clients.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
- ● This is a fund, not an operating company
MoonshotScore History
Recorded daily since 2026-08-23 · 42 snapshots
| 2026-08-23 | 44 |
| 2026-08-31 | 44 |
| 2026-09-08 | 44 |
| 2026-09-16 | 44 |
| 2026-09-24 | 44 |
| 2026-10-04 | 44 |
| 2026-10-05 | 44 |
What changed?
The score has stayed at 44.
Over the same 30 days the stock moved -1.3%.
FACTX Financials
Bull Case vs Bear Case
Bull Case
- Specialized focus on the healthcare sector.
- Experienced management team at Fidelity Investments.
- Diversified portfolio of healthcare stocks.
- Access to Fidelity's research and resources.
Bear Case
- Concentrated sector exposure increases risk.
- Performance is highly dependent on the healthcare industry's performance.
- Subject to regulatory and political risks in the healthcare sector.
- No dividend yield may deter some investors.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
FACTX Latest News
No recent news available for FACTX.
FACTX Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for FACTX.
Price Targets
Wall Street price target analysis for FACTX.
FACTX MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for FACTX; grades run from A+ (80-100) to F (below 30).
FACTX Financials Stock FAQ
What do analysts say about FACTX stock?
As of March 17, 2026, there is no specific analyst rating available for FACTX as it is a mutual fund, not a stock.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- The information provided is based on available data and is subject to change.
- Investment decisions should be made based on individual circumstances and risk tolerance.